Open original FDA record ↗Recall record
- FDA identifier
- Z-0464-2025
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA classification date
- Nov 14, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The IMMULITE 2000 PSA assay for use on the IMMULITE 2000 and IMMULITE 2000 XPi analyzers did not meet the High-dose Hook Effect claim as stated in the Instructions for Use (IFU).
Source facts
- Action
- An Urgent Medical Device Correction letter dated 9/30/24 was sent to customers. Customer Actions " Please review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, that may have been affected. " Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. " Please retain this letter with your laboratory records and forward this letter to those who may have received this product. Resolution IMMULITE 2000 and IMMULITE 2000 XPi kit lots D168 and above meet the IFU high-dose hook effect claim. Siemens continues to investigate root cause of the issue observed with the impacted kit lots. If you have any questions, please contact your Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative. Please send a scanned copy of the completed form via email to uscctsfcaecfax.team@siemens-healthineers.com. Or to fax this completed form to the Customer Care Center at (312) 275-7795.
- Initiated
- 2024-09-30
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution.
- Recall number
- Z-0464-2025
- Recall status
- Open, Classified
- CDRH record ID
- 210461
- FDA classified
- 2024-11-14
- Recall event number
- 95513